6 unknown. 6 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Unknown 6 |
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Cellcept: new trials by email Literature Review of Cellcept trials Research Report on Cellcept
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment Efficacy of Corticosteroids and Mycophenolate Mofetil in Patients With Immune Related Hepatitis Mycophenolate Mofetil, Solu-Medrol, Ursodeoxycholic acid - Hepatitis, Drug-Induced | Phase 2 | Unknown | Inge Marie Svane | 60 | 2021-04-07 | 2022-12-14 |
| Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma rituximab, ibritumomab tiuxetan, anti-thymocyte globulin - Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma | Phase 2 | Unknown | Joseph Tuscano | 20 | 2013-03-12 | 2022-11-30 |
| Treatment of Children With Kidney Transplants by Injection of CD4+CD25+FoxP3+ T Cells to Prevent Organ Rejection CD4+CD25+CD127lowFoxP3+ T regulatory cells injection, Alemtuzumab, Mycophenolate mofetil - End-Stage Renal Disease, Kidney Failure | Phase 1 / Phase 2 | Unknown | Pirogov Russian National Research Medical University | 30 | 2011-10-01 | 2011-11-18 |
| Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens Mycophenolate mofetil, Sirolimus - Graft-Versus-Host Disease, Hematological Malignancies | Phase 2 | Unknown | University of Liege | 200 | 2011-09-01 | 2024-05-09 |
| Safety and Efficacy Study of Allogenic Mesenchymal Stem Cells to Treat Extensive Chronic Graft Versus Host Disease Mesenchymal stem cell (MSC), Prednisone and cyclosporine or primary therapies - Graft Versus Host Disease | Phase 2 | Unknown | Guangdong Provincial People's Hospital | 52 | 2009-09-01 | 2014-08-26 |
| Safety and Efficacy in LPL-Deficient Subjects of AMT-011, an Adeno-Associated Viral Vector Expressing Human Lipoprotein Lipase [S447X] Alipogene Tiparvovec (AMT-011), Human LPL [S447X], Mycophenolate mofetil, cyclosporine - Familial Lipoprotein Lipase Deficiency | Phase 2 / Phase 3 | Unknown | Amsterdam Molecular Therapeutics | 14 | 2007-08-01 | 2011-09-30 |
Graft vs Host Disease (2) · Chemical and Drug Induced Liver Injury (1) · Hematologic Neoplasms (1) · Hepatitis (1) · Hyperlipoproteinemia Type I (1) · Kidney Failure, Chronic (1) · Lymphoma, Non-Hodgkin (1) · Neoplasms (1) · Renal Insufficiency (1)
Amsterdam Molecular Therapeutics (1) · Guangdong Provincial People's Hospital (1) · Inge Marie Svane (1) · Joseph Tuscano (1) · Pirogov Russian National Research Medical University (1) · University of Liege (1)
Belgium (1) · Canada (1) · China (1) · Denmark (1) · Russia (1) · United States (1)
Inge M Svane (1) · Joseph Tuscano (1) · Michael M. Kaabak, M.D. Ph.D. (1) · Svetlana N. Bykovskaia, M.D. Ph.D. (1) · Xin Du, MD.PhD. (1)